PugeatMMDunnJFNisulaBC. Transport of steroid hormones: Interaction of 70 drugs with testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab1981; 53: 69–75
2.
LiddleGW. Tests of pituitary adrenal suppressibility in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab1960; 20: 1539–60
3.
NugentCANicholsTTylerFH. Diagnosis of Cushing's syndrome—single dose dexamethasone suppression test. Arch Int Med1965; 116: 172–6
4.
NicholsTNugentCATaylorFH. Steroid laboratory tests in the diagnosis of Cushing's syndrome. Am J Med1968; 45: 116–28
5.
BarthJSethJHowlettTAFreedmanDB. A survey of endocrine function testing by clinical biochemistry laboratories in the UK. Ann Clin Biochem1995; 32: 442–9
6.
CarrollBJ. The dexamethasone test for melancholia. Br J Psychiat1982; 140: 292
7.
BrownWAHaserRJQuailsCB. Dexamethasone suppression test identifies subtypes of depression which respond to different anti-depressants. Lancet1980; i: 928
8.
PeselowEDFieveRR. Dexamethasone suppression test and response to anti-depressants in depressed patients. N Engl J Med1982; 19: 1216
9.
MeikleAW. Dexamethasone suppression tests: Usefulness of simultaneous measurement of plasma Cortisol and dexamethasone. Clin Endocrinol1982; 16: 401–8
OdagiriEDemuraRDemuraHSudaTIshiwatariNAbeY. The changes in plasma Cortisol and urinary free Cortisol by an overnight dexamethasone suppression test in patients with Cushing's disease. Endocrinol Japon1988; 35: 795–802
12.
CrapoL. Cushing's syndrome: A review of diagnostic tests. Metabolism1979; 28: 955–77
13.
WeinerMF. Age and Cortisol suppression by dexamethasone in normal subjects. J Psychiat Res1989; 23: 163–8
14.
JubizWMeikleAWLevinsonRAMizutaniSWestCDTylerFH. Effect of diphenylhydantoin on the metabolism of dexamethasone in humans. N Engl J Med1970; 283: 11–14
15.
RushAJSchlesserMAGilesDECrowleyGTFairchildCAttshulerKZ. The effect of dosage on the dexamethasone test in normal controls. Psychiat Res1982; 7: 277–85
16.
TillerJWMaguireKPSchweitzerIBiddleNCampbellDGOutchK. The dexamethasone suppression test: A study in a normal population. Psychoneuroendocrinology1988; 13: 377–84
CroninCIgoeIDuffyMJCunninghamSKMcKennaTJ. The overnight dexamethasone test is a worthwhile screening procedure. Clin Endocrinol1990; 33: 27–33
19.
EdelsteinCKRoy-ByrnePFawzyFIDornfieldL. Effects of weight loss on the dexamethasone suppression test. Am J Psychiat1983; 140: 338–41
20.
ReschiniEGiustinaG. Clinical experience with a simple screening test for Cushing's syndrome combining the determination of plasma Cortisol circadian rhythm with the overnight dexamethasone suppression test. Am J Med Sci1978; 275: 33–42
21.
O'BrienJTSchweitzerIAmesDTuckwellVMastwykM. Cortisol suppression by dexamethasone in the healthy elderly: Effects of age, dexamethasone levels and cognitive function. Biol Psychiat1994; 36: 389–94
22.
MendiewiczJCharlesGFrancksonJM. The dexamethasone suppression test in affective disorder: Relationship to clinical and genetic subgroups. Br J Psychiat1982; 141: 464–70
23.
HaierRJKestnerGI. Sensitivity and specificity of 1 and 2 mg dexamethasone suppression tests. Psychiat Res1982; 7: 271–6
24.
WhalleyLJBorthwickNCopolovDDickHChristieJEFinkG. Glucocorticoid receptors and depression. BMJ1986; 292: 859–61
25.
LampeTHFarissBLRisseSCRaskindMAPlymateSR. Laboratory evaluation for Cushing's syndrome in psychiatric patients with Cortisol non-suppression following the overnight dexamethasone suppression test. Biol Psychiat1987; 22: 1264–70
26.
GoldPWLoriauxDLRoyAKlingMACalabreseJRKellnerCH. Responses to corticotrophin releasing hormone in the hypercortisolism of depression and Cushing's disease. N Engl J Med1986; 314: 1329–35
27.
ConnollyCKGoreMBRStanleyWWillisMR. Single dose dexamethasone suppression in normal subjects and hospitalised patients. BMJ1965; 21: 665–7
NewsomGMurrayN. Reversal of dexamethasone suppression test non-suppression in alcohol abusers. Am J Psychiat1983; 140: 353–1
30.
RamirezGGomez-SanchezCMeikleWAJubizW. Evaluation of the hypothalamic-hypophysealadrenal axis in patients receiving long-term haemodialysis. Ann Intern Med1982; 142: 1448–52
31.
WorkmanRJVaughnWKStoneWJ. Dexamethasone suppression testing in chronic renal failure. Pharmacokinetics of dexamethasone and demonstration of a normal hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab1986; 63: 741–6
32.
HaighSETevaarwerkGJ. A rise in the glomerular filtration rate as a cause of a “paradoxical” increase in urinary free Cortisol during dexamethasone suppression in a patient with an adrenal adenoma: A case report. Clin Endocrinol1981; 15: 53–6
33.
BrownRDVan LoonGROrthDNLiddleGW. Cushing's disease with periodic hormonogenesis. One explanation for paradoxical response to dexamethasone. J Clin Endocrinol Metab1973; 36: 445–51
34.
LibermanBWajchenbergBTambasciaMAMesquitaCH. Periodic remission in Cushing's disease with paradoxical dexamethasone response: An expression of periodic hormonogenesis. J Clin Endocrinol Metab1976; 43: 913–8
35.
AtkinsonABKennedyALCarsonDJHaddenDRWeaverJASheridanB. Five cases of cyclical Cushing's syndrome. BMJ1985; 291: 1453–9
36.
MonteleonePPiccoloAMartinoMMajM. Seasonal variation in the dexamethasone test: A longitudinal study in chronic schizophrenics and in healthy subjects. Neuropsychobiology1994; 30: 61–5
37.
YerevanianBIAndersonJLMilaneseE. Effect of weekly testing on dexamethasone suppression test results in normal subjects. Psychiat Res1985; 14: 209–13
38.
KennedyLAtkinsonABJohnstonMSheridanBHaddenDR. Serum Cortisol concentrations during low dose dexamethasone suppression test to screen for Cushing's syndrome. BMJ1984; 289: 1188–91
39.
McHardy-YoungSHarrisPWRLessofMH. Single dose dexamethasone suppression test for Cushing's syndrome. BMJ1967; 2: 740–4
40.
SeidenstickerJFFolkRCWielandRGHamwiGJ. Screening test for Cushing's syndrome with plasma 11-hydroxycorticosteroids. J Am Med Soc1967; 202: 87–90
41.
NishidaSMatsumuraSHorinoMOyamaHTenkuA. Single dose four hour dexamethasone suppression test in normal men and its application for the diagnosis of Cushing's syndrome. Steroids1976; 28: 411–21
42.
HindmarshPCBrookCG. Single dose dexamethasone suppression test in children: Dose relationship to body size. Clin Endocrinol1985; 23: 67–70
43.
AtkinsonABMcAteerEJHaddenDRKennedyALSheridanBTraubAI. A weight-related intravenous dexamethasone suppression test distinguishes obese controls from patients with Cushing's syndrome. Acta Endocrinol1989; 120: 753–9
44.
JamesVHTLandonJ. Hypothalamic-Pituitary-Adrenal Function Tests: A Working Guide For Clinicians and Laboratory Staff.London: Cambridge University Press, 1968
45.
BlethenSLChasalowFI. Overnight dexamethasone suppression test: Normal responses and the diagnosis of Cushing's syndrome. Steroids1989; 54: 185–93
46.
MontwillJIgoeDMcKennaTJ. The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome. Steroids1994; 59: 296–8
47.
Newell-PriceJTrainerPPerryLWassJGrossmanABesserM. A sleeping midnight Cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome. Clin Endocrinol1995; 43: 545–50
48.
HankinMEThealeHMSteinbeckAW. An evaluation of laboratory tests for the detection and differential diagnosis of Cushing's syndrome. Clin Endocrinol1977; 6: 185–96